We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma.
- Authors
Hassan, Siti Nazihahasma; Mohamed Yusoff, Abdul Aziz; Idris, Zamzuri; Mohd Redzwan, Norhanani; Ahmad, Farizan
- Abstract
The resistance, plasticity and heterogeneity of cancer cells, including glioblastoma (GB) cells, have prompted the investigation of various agents for possible adjuncts and alternatives to existing therapies. This includes a macrolide antibiotic, azithromycin (AZI). It possesses intriguing anticancer properties in a range of cancer models in vitro, such as antiproliferative, pro‐apoptotic, anti‐autophagy and anti‐angiogenic effects. In fact, AZI is renowned for its ability to eradicate cancer stem cells by inhibiting mitochondrial biogenesis and respiration. AZI‐containing regimens in cancer patients for different purposes have shown favourable (i.e., attributed to its antibacterial activity) and unfavourable outcomes. Whilst its direct anticancer effects have yet to be clinically proven. To that end, this review provides a summary of AZI anticancer studies and delineates its potential activities in overcoming the challenges of GB.
- Subjects
AZITHROMYCIN; GLIOBLASTOMA multiforme; MACROLIDE antibiotics; CANCER stem cells; ANTINEOPLASTIC agents
- Publication
Fundamental & Clinical Pharmacology, 2023, Vol 37, Issue 5, p918
- ISSN
0767-3981
- Publication type
Academic Journal
- DOI
10.1111/fcp.12900